biomarker sensing in interstitial fluid

Adaptyx Biosciences is developing a wearable patch platform that turns lab-grade biochemical assays into a continuous data stream for AI-powered care. The minimally-invasive dermal probe uses programmable molecular switches to interrogate biomarkers in interstitial fluid, feeding algorithms and clinician dashboards. The product is in development and not FDA-approved or for sale.

Read more

AI & data analyticscontinuous biomarker monitoringprogrammable molecular switches